ArticleJournal of translational medicine2023

BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists.

Ling Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.